Skip to main content

Cambridge Innovation Capital — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

52
Companies
$687.6M
Total invested
$18.1M
Avg. check
35
Industries
Biotechnology 11Medical 7Health Care 6Software 6Therapeutics 6Artificial Intelligence (AI) 5+29 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 52
PetMedix
September 2021

PetMedix is a pet therapeutics startup.

Biotechnology · Cambridge$37.2M Series B
Origami
September 2022

Origami is an intelligent trading and automation software for short term power trading.

Energy · Cambridge$6.2M Venture - Series Unknown
Unlikely AI
September 2022

Unlikely AI is a talented group that is approaching artificial intelligence from a daring, fresh angle.

Artificial Intelligence (AI) · London$20.3M Seed
Phosphor AI
August 2023

Phosphor AI provides personalized AI tutoring solutions for secondary education.

Education · Cambridge$2.5M Seed
Microbiotica
August 2024

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

Biotechnology · CambridgeVenture - Series Unknown
Pretzel Therapeutics
July 2025

Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.

Biotechnology · WalthamVenture - Series Unknown
TRIMTECH Therapeutics
June 2026

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

Biotechnology · Cambridge$14.0M Seed
Undo
June 2026

Undo is a technology company that offers time travel debugging services for Linux.

Developer Tools · Cambridge$37.0M Private Equity
Trent AI
April 2026

Trent AI is an agentic AI safety platform that provides unnoticed, automatic protection for LLMs and AI processes.

Agentic AI · London$12.7M Seed
Mosaic Therapeutics
April 2025

Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients.

Biotechnology · CambridgeCorporate Round
CMR Surgical
April 2025

CMR Surgical develops and manufactures robotic surgical systems to enhance precision and efficiency in minimally invasive surgery.

Health Care · Cambridge$200.0M Venture - Series Unknown
Complement Therapeutics
April 2023

Complement Therapeutics operates as a preclinical stage company.

Biotechnology · London$78.7M Series A
Storm Therapeutics
April 2026

Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.

Biotechnology · Cambridge$56.0M Series C
Immutrin
March 2026

Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.

Biotechnology · Cambridge$87.1M Series A
PredictImmune
March 2023

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

Biopharma · CambridgeGrant
Sortera Bio
June 2025

Sortera Bio operates as a biotechnology company.

Biotechnology · Cambridge$10.2M Pre-Seed
PervasID
April 2025

PervasID is developing a high reliability

Developer Tools · Cambridge$264K Venture - Series Unknown
Cambridge GaN Devices
February 2025

Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.

Electronics · Cambridge$32.0M Series C
Salience Labs
February 2025

Salience Labs offers photonic solutions designed to enhance connectivity for AI data center infrastructure.

Artificial Intelligence (AI) · Oxford$30.0M Series A
Forefront RF
November 2024

Forefront RF is a fabless semiconductor company.

Semiconductor · Cambridge$20.8M Series A
Riverlane
August 2024

Riverlane develops software solutions to harness the power of quantum computers for practical applications.

Computer · Cambridge$75.0M Series C
Secondmind
November 2023

Machine learning for automotive innovators

Artificial Intelligence (AI) · Cambridge$16.0M Venture - Series Unknown
Seldon
March 2023

Seldon is a machine learning deployment platform.

Artificial Intelligence (AI) · London$20.0M Series B
Gyroscope Therapeutics
November 2021

Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.

Biotechnology · Stevenage$60.0M Corporate Round

Where Cambridge Innovation Capital invests

Biotechnology11
Medical7
Health Care6
Software6
Therapeutics6
Artificial Intelligence (AI)5

About Cambridge Innovation Capital's portfolio

How many companies has Cambridge Innovation Capital invested in?

Cambridge Innovation Capital has invested in 52 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Cambridge Innovation Capital invest in?

Cambridge Innovation Capital's top investment sectors include Biotechnology, Medical, Health Care, Software, Therapeutics. The firm invests across 35 different industry categories.

What is Cambridge Innovation Capital's largest investment?

Among tracked funding rounds, CMR Surgical received $200.0M in a Venture - Series Unknown round. Cambridge Innovation Capital's total known invested capital is $687.6M.

What is the average investment size for Cambridge Innovation Capital?

Cambridge Innovation Capital's average investment size is $18.1M across its portfolio of 52 companies.

What are Cambridge Innovation Capital's most recent investments?

Recent Cambridge Innovation Capital portfolio additions include PetMedix, Origami, Unlikely AI, Phosphor AI, Microbiotica. These companies were founded in 2020 or later.

Reach the founders behind these 52 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →